These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3089407)

  • 1. Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment.
    Gossop M; Johns A; Green L
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):103-4. PubMed ID: 3089407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate withdrawal: inpatient versus outpatient programmes.
    McBride A
    Br Med J (Clin Res Ed); 1986 Aug; 293(6545):505-6. PubMed ID: 3091182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pregabalin for the reduction of opiate withdrawal symptoms].
    Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
    Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.
    Hayashida M; Alterman AI; McLellan AT; O'Brien CP; Purtill JJ; Volpicelli JR; Raphaelson AH; Hall CP
    N Engl J Med; 1989 Feb; 320(6):358-65. PubMed ID: 2913493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate withdrawal: inpatient versus outpatient programmes.
    Brewer C
    Br Med J (Clin Res Ed); 1986 Aug; 293(6543):391. PubMed ID: 3089534
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding.
    Clark TJ; Middleton LJ; Cooper NA; Diwakar L; Denny E; Smith P; Gennard L; Stobert L; Roberts TE; Cheed V; Bingham T; Jowett S; Brettell E; Connor M; Jones SE; Daniels JP
    Health Technol Assess; 2015 Jul; 19(61):1-194. PubMed ID: 26240949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the structure of admissions and the course of hospitalization of drug addicts treated at the I Clinic for Mental Diseases, Medical Academy, in Gdańsk 1982-1988].
    Magiera P; Badzio-Jagiełło H
    Psychiatr Pol; 1990; 24(6):1-7. PubMed ID: 2131478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance treatment for opiate dependence at a naltrexone clinic].
    López-Ibor Aliño JJ; Pérez de los Cobos JC; Ochoa E; Hernández Herreros M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(5):296-305. PubMed ID: 1963258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on gabapentin in the treatment of opiate withdrawal.
    Martínez-Raga J; Sabater A; Perez-Galvez B; Castellano M; Cervera G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):599-601. PubMed ID: 15093968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of opiate withdrawal.
    Upthegrove RA; Naik PC
    Hosp Med; 2001 May; 62(5):277, 280-1. PubMed ID: 11385887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemocarboperfusion in the treatment of patients with an opiate abstinence syndrome].
    Kirkovskiĭ VV; Laban' FN; Kremenevskiĭ IV; Starostin AV; Dus' DD; Rovdo IM
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(9):44-5. PubMed ID: 9410602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is inpatient medical alcohol detoxification justified: results of a randomized, controlled study.
    Hayashida M; Alterman A; McLellan T; Mann S; Maany I; O'Brien C
    NIDA Res Monogr; 1988; 81():19-25. PubMed ID: 3136360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal opiate withdrawal.
    Rivers RP
    Arch Dis Child; 1986 Dec; 61(12):1236-9. PubMed ID: 3813619
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient restless legs-like syndrome as a complication of opiate withrawal.
    Scherbaum N; Stüper B; Bonnet U; Gastpar M
    Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal.
    O'Connor PG; Gottlieb LD; Kraus ML; Segal SR; Horwitz RI
    J Gen Intern Med; 1991; 6(4):312-6. PubMed ID: 1890501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient versus other settings for detoxification for opioid dependence.
    Day E; Ison J; Strang J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004580. PubMed ID: 15846721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal.
    Rosen MI; Pearsall HR; Woods SW; Kosten TR
    Neuropsychopharmacology; 1996 Mar; 14(3):187-93. PubMed ID: 8866702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.